Gastroenterology
Celiac Disease
Diagnose celiac disease while the patient is consuming gluten, using tTG-IgA plus total IgA first. In adults, confirm positive serology with properly sampled duodenal biopsies, then use a strict gluten-free diet, dietitian-led exposure review, and targeted reassessment for persistent symptoms or villous atrophy.
Diagnosis
Test before gluten withdrawal
Serology and histology lose diagnostic utility after gluten restriction.
For a patient with suspected celiac disease, obtain serum tTG-IgA and total serum IgA while the patient continues a gluten-containing diet. This paired approach is the concordant guideline-supported first-line strategy in adults and children because isolated tTG-IgA can be falsely negative with concurrent IgA deficiency. PubMed+1PubMedCurrent guidelines for the management of celiac disease - PMCPubMedExecutive Summary - Diagnosis of Celiac Disease - NCBI Bookshelf
If total IgA is deficient, use IgG-based celiac serology rather than interpreting a negative tTG-IgA as exclusion. Available assays include IgG tTG and IgG deamidated gliadin peptide (DGP); DGP-IgG is particularly useful in early childhood and may identify affected children younger than 2 years when conventional IgA markers are negative. ScienceDirect+3ScienceDirectThe anti-deamidated gliadin peptide antibodies unmask celiac disease in small children with chronic diarrhoea - ScienceDirectScienceDirectEvaluating diagnostic accuracy of anti-tissue Transglutaminase IgA antibodies as first screening for Celiac Disease in very young children - ScienceDirectPubMedDigesting all the options: laboratory testing for celiac disease - PubMedPubMedCeliac disease: a comprehensive current review - PMC
Do not use native antigliadin antibodies as the principal diagnostic assay. EMA-IgA is highly specific but less sensitive than tTG-IgA in pooled evidence and is most useful as a confirmatory serologic test when results, pretest probability, or a pediatric no-biopsy pathway require greater specificity. PubMed+2PubMedResults - Diagnosis of Celiac Disease - NCBI BookshelfPubMedDigesting all the options: laboratory testing for celiac disease - PubMedPubMedCeliac disease: a comprehensive current review - PMC
A negative tTG-IgA obtained after self-initiated gluten avoidance does not reliably exclude celiac disease; serology, biopsy, and capsule testing other than HLA typing require ongoing gluten exposure. PubMedPubMedExecutive Summary - Diagnosis of Celiac Disease - NCBI Bookshelf
Avoid diagnosing celiac disease from HLA-DQ2 or HLA-DQ8 positivity alone: these haplotypes occur in 30% to 40% of Western Caucasian populations, whereas only about 3% of carriers develop disease. ScienceDirectScienceDirectHLA DQ2 Antigen - an overview | ScienceDirect Topics
Use HLA typing as an exclusion-oriented adjunct in selected discordant or gluten-restricted cases, not as routine confirmation in a patient with compatible serology and histology. ScienceDirect+2ScienceDirectHLA DQ2 Antigen - an overview | ScienceDirect TopicsScienceDirectFunction of DQ2 and DQ8 as HLA susceptibility molecules in celiac disease - ScienceDirectPubMedExecutive Summary - Diagnosis of Celiac Disease - NCBI Bookshelf
Confirmation
When to perform duodenal biopsy
In adults, histologic confirmation remains the usual endpoint of the diagnostic evaluation.
Refer adults with positive celiac serology for upper endoscopy with duodenal biopsies while they remain on gluten. Across current guidelines, endoscopy with duodenal biopsies remains mandatory for a final adult diagnosis, except in limited settings where endoscopy or expert pathology is unavailable. PubMedPubMedCurrent guidelines for the management of celiac disease - PMC
Interpret pathology with attention to specimen orientation and assessment of well-oriented villous-crypt units. Poor orientation can misclassify villous architecture; morphometric villous-height-to-crypt-depth measurements may improve interobserver agreement compared with non-morphometric assessment. NatureNatureGuidelines for best practices in monitoring established ...
When tTG-IgA and histology conflict, first confirm that the patient was consuming gluten and that specimens were adequate and correctly interpreted. In adults, repeat small-intestinal biopsy, including jejunal sampling, can be considered for discordant histopathology and tTG-IgA; in children, re-cutting tissue blocks or expert pathology review is generally preferred before repeat endoscopy. PubMedPubMedCurrent guidelines for the management of celiac disease - PMC
Do not apply the European pediatric serology-only pathway to routine U.S. adult diagnosis. ESPGHAN criteria use tTG greater than 10 times the upper limit of normal plus EMA and HLA testing, but this approach has not been adopted by U.S. societies. PubMed+1PubMedExecutive Summary - Diagnosis of Celiac Disease - NCBI BookshelfPubMedCeliac disease: a comprehensive current review - PMC
Positive serology with normal duodenal architecture represents potential celiac disease. Distinguish it from established enteropathy and individualize follow-up because management remains controversial. PubMedPubMedInsights From Potential Celiac Disease as a Paradigm of ...
Use wireless capsule endoscopy to assess small-bowel mucosa or complications in complicated celiac disease, not as the standard initial confirmation test when duodenal biopsy is feasible. PubMedPubMedReview and Critical Appraisal of Clinical Practice Guidelines of Modalities Used in the Diagnosis of Celiac Disease
| Result pattern | Primary concern | Next action |
|---|---|---|
| Positive tTG-IgA, normal total IgA, compatible duodenal injury | Established celiac disease | Initiate a strict gluten-free diet and baseline nutritional assessment. PubMed+1PubMedCurrent guidelines for the management of celiac disease - PMCPubMedFollow-Up of Celiac Disease in Adults: “When, What, Who, and Where” |
| Positive tTG-IgA, normal villi | Potential celiac disease, sampling limitation, or another explanation for seropositivity | Verify gluten exposure and biopsy adequacy; use clinical context and planned follow-up rather than assuming symptoms are gluten-mediated. Nature+1NatureGuidelines for best practices in monitoring established ...PubMedInsights From Potential Celiac Disease as a Paradigm of ... |
| Negative serology, compatible clinical suspicion | IgA deficiency, inadequate gluten exposure, or alternative enteropathy | Check total IgA, use IgG-based assays when appropriate, and consider biopsy if suspicion remains high. PubMed+2PubMedCurrent guidelines for the management of celiac disease - PMCPubMedDigesting all the options: laboratory testing for celiac disease - PubMedPubMedExecutive Summary - Diagnosis of Celiac Disease - NCBI Bookshelf |
| Positive serology, nondiagnostic or conflicting histology | Sampling, orientation, interpretation, or true discordance | Obtain expert pathology review; consider repeat small-bowel biopsy in adults. Nature+1NatureGuidelines for best practices in monitoring established ...PubMedCurrent guidelines for the management of celiac disease - PMC |
Management
Institute a strict gluten-free diet after diagnosis
Dietary treatment must be paired with objective assessment of malabsorption and implementation quality.
Treat confirmed celiac disease with a strict gluten-free diet that excludes gluten-containing foods, beverages, and medications. Complete gluten removal is the cornerstone of management and should lead toward symptomatic, serologic, and histologic remission, although mucosal healing is incomplete in some adults despite symptom resolution and normalized antibodies. Nature+2NatureGuidelines for best practices in monitoring established ...ScienceDirectGluten-related disorders: monitoring and follow-up - ScienceDirectScienceDirectFollow-up of patients with celiac disease: Achieving compliance with treatment - ScienceDirect
Refer at diagnosis to a dietitian with celiac-disease and gluten-free-diet expertise. The dietitian should review hidden and inadvertent gluten exposures, practical dietary knowledge, and nutritional adequacy; this intervention is central when symptoms or serologic abnormalities persist. PubMedPubMedFollow-Up of Celiac Disease in Adults: “When, What, Who, and Where”
At baseline and during follow-up, identify nutritional abnormalities and confirm their correction with laboratory testing rather than relying on symptom response. Guidelines emphasize monitoring nutritional status and laboratory abnormalities detected at diagnosis or follow-up because villous recovery and absorptive function do not reliably track with symptoms or antibody normalization. Nature+1NatureGuidelines for best practices in monitoring established ...PubMedFollow-Up of Celiac Disease in Adults: “When, What, Who, and Where”
Document the baseline celiac serology assay and value so the same marker can be trended after treatment. PubMed+1PubMedFollow-Up of Celiac Disease in Adults: “When, What, Who, and Where”ScienceDirectFollow-up of patients with celiac disease: Achieving compliance with treatment - ScienceDirect
Do not interpret symptom improvement alone as proof of mucosal recovery; persistent villous injury may occur without symptoms or elevated celiac-related antibody titers. NatureNatureGuidelines for best practices in monitoring established ...
For confirmed celiac disease in children and adolescents with diabetes, treatment is a gluten-free diet to prevent complications. Diabetes JournalsDiabetes Journals14. Children and Adolescents: Standards of Medical Care in ...
Monitoring
Escalate persistent symptoms or abnormal follow-up findings
Persistent disease after treatment is a diagnostic problem before it is a refractory-celiac diagnosis.
At structured follow-up, reassess symptoms, gluten-free-diet implementation, celiac serology, nutritional status, and correction of baseline laboratory abnormalities. Current follow-up recommendations combine history, serology, and laboratory testing, with celiac-experienced dietitian participation to assess adherence and nutritional adequacy. PubMedPubMedFollow-Up of Celiac Disease in Adults: “When, What, Who, and Where”
Perform follow-up biopsy when strict diet adherence is reported but clinically meaningful symptoms, nutritional abnormalities, or concern for persistent enteropathy remains. Histologic recovery cannot be inferred from negative serology or symptom control; biopsy samples should be adequately oriented and assessed for residual villous injury. NatureNatureGuidelines for best practices in monitoring established ...
For nonresponsive celiac disease, use a systematic reassessment rather than empirically labeling refractory disease. Confirm the original diagnosis, conduct a detailed gluten-exposure review, reassess histology when indicated, and evaluate competing causes of ongoing symptoms or enteropathy before escalating to a refractory-celiac pathway. PubMedPubMedManagement Strategy for Non-Responsive and Refractory Celiac Disease in Adults: A Review Article
Treat newly abnormal or persistent nutritional deficits as an indication to reassess both dietary exposure and ongoing absorptive dysfunction. Nature+1NatureGuidelines for best practices in monitoring established ...PubMedFollow-Up of Celiac Disease in Adults: “When, What, Who, and Where”
Use capsule endoscopy when complicated celiac disease requires small-bowel mucosal or complication assessment; it is recommended in guidelines for evaluation of complicated disease. PubMedPubMedReview and Critical Appraisal of Clinical Practice Guidelines of Modalities Used in the Diagnosis of Celiac Disease
Refer suspected refractory celiac disease early to a multidisciplinary center with expertise in complex celiac disease, particularly when persistent villous atrophy is documented despite strict dietary review. PubMedPubMedManagement Strategy for Non-Responsive and Refractory Celiac Disease in Adults: A Review Article
Nonresponsive versus refractory disease
Nonresponsive celiac disease denotes persistent symptoms, signs, laboratory abnormalities, or enteropathy after a gluten-free diet and requires a broad diagnostic re-evaluation. Refractory celiac disease is a narrower diagnosis that should be considered only after excluding ongoing gluten exposure, diagnostic error, and alternative causes of persistent disease. PubMedPubMedManagement Strategy for Non-Responsive and Refractory Celiac Disease in Adults: A Review Article
Refractory celiac disease type II warrants particular urgency because recommendations are based largely on retrospective cohorts, small open-label studies, and expert opinion, and because of its association with severe complications including lymphoma. PubMed+1PubMedManagement Strategy for Non-Responsive and Refractory Celiac Disease in Adults: A Review ArticleScienceDirectGluten-related disorders: monitoring and follow-up - ScienceDirect
Use cross-sectional enterography or capsule evaluation selectively when concern exists for small-bowel neoplasm or inflammatory small-bowel pathology in complicated disease. PubMed+1PubMedReview and Critical Appraisal of Clinical Practice Guidelines of Modalities Used in the Diagnosis of Celiac Diseasepubs rsnaCT and MR Enterography in the Evaluation of Celiac Disease
Case Finding
Use targeted testing in high-risk clinical settings
Testing is most useful when a compatible syndrome or high-risk condition creates meaningful pretest probability.
In children and adolescents with type 1 diabetes, celiac disease screening is particularly relevant because most cases are diagnosed within 5 years after diabetes diagnosis. Screening uses celiac serology, including tTG or antiendomysial antibodies, with small-bowel biopsy used to establish the diagnosis when indicated. Diabetes Journals+1Diabetes Journals14. Children and Adolescents: Standards of Care in Diabetes ...Diabetes JournalsStandards of Medical Care in Diabetes—2014
For patients undergoing upper endoscopy for other reasons, obtain duodenal biopsies when characteristic endoscopic features raise concern for celiac disease. Endoscopic appearance should not replace histologic assessment in adults with suspected disease. PubMed+1PubMedReview and Critical Appraisal of Clinical Practice Guidelines of Modalities Used in the Diagnosis of Celiac DiseasePubMedCurrent guidelines for the management of celiac disease - PMC
Avoid broad reliance on HLA positivity to screen asymptomatic people: DQ2/DQ8 carriage is common and has limited positive predictive value. HLA testing is more clinically useful when its absence can help resolve a difficult diagnostic question. ScienceDirect+1ScienceDirectHLA DQ2 Antigen - an overview | ScienceDirect TopicsScienceDirectFunction of DQ2 and DQ8 as HLA susceptibility molecules in celiac disease - ScienceDirect
A tTG-IgA result above 10 times the assay upper limit of normal is part of a pediatric European no-biopsy strategy when supported by EMA and HLA testing, but U.S. practice has not adopted that pathway routinely. PubMed+1PubMedExecutive Summary - Diagnosis of Celiac Disease - NCBI BookshelfPubMedCeliac disease: a comprehensive current review - PMC
In low-pretest-probability settings, a positive serology should prompt confirmatory evaluation rather than immediate lifelong dietary restriction. PubMed+1PubMedCurrent guidelines for the management of celiac disease - PMCPubMedExecutive Summary - Diagnosis of Celiac Disease - NCBI Bookshelf
References
- Guidelines for best practices in monitoring established ... — www.nature.com · www.nature.com
- The anti-deamidated gliadin peptide antibodies unmask celiac disease in small children with chronic diarrhoea - ScienceDirect — www.sciencedirect.com · www.sciencedirect.com
- HLA DQ2 Antigen - an overview | ScienceDirect Topics — www.sciencedirect.com · www.sciencedirect.com
- Function of DQ2 and DQ8 as HLA susceptibility molecules in celiac disease - ScienceDirect — www.sciencedirect.com · www.sciencedirect.com
- Evaluating diagnostic accuracy of anti-tissue Transglutaminase IgA antibodies as first screening for Celiac Disease in very young children - ScienceDirect — www.sciencedirect.com · www.sciencedirect.com
- Current guidelines for the management of celiac disease - PMC — pmc.ncbi.nlm.nih.gov · pmc.ncbi.nlm.nih.gov
- Management Strategy for Non-Responsive and Refractory Celiac Disease in Adults: A Review Article — pmc.ncbi.nlm.nih.gov · pmc.ncbi.nlm.nih.gov
- Follow-Up of Celiac Disease in Adults: “When, What, Who, and Where” — pmc.ncbi.nlm.nih.gov · pmc.ncbi.nlm.nih.gov
- Review and Critical Appraisal of Clinical Practice Guidelines of Modalities Used in the Diagnosis of Celiac Disease — pmc.ncbi.nlm.nih.gov · pmc.ncbi.nlm.nih.gov
- Insights From Potential Celiac Disease as a Paradigm of ... — pubmed.ncbi.nlm.nih.gov · pubmed.ncbi.nlm.nih.gov
- A systematic review of celiac disease recommendations for ... — pubmed.ncbi.nlm.nih.gov · pubmed.ncbi.nlm.nih.gov
- Results - Diagnosis of Celiac Disease - NCBI Bookshelf — www.ncbi.nlm.nih.gov · www.ncbi.nlm.nih.gov
- Digesting all the options: laboratory testing for celiac disease - PubMed — www.ncbi.nlm.nih.gov · www.ncbi.nlm.nih.gov
- Executive Summary - Diagnosis of Celiac Disease - NCBI Bookshelf — www.ncbi.nlm.nih.gov · www.ncbi.nlm.nih.gov
- Celiac disease: a comprehensive current review - PMC — www.ncbi.nlm.nih.gov · www.ncbi.nlm.nih.gov
- 14. Children and Adolescents: Standards of Medical Care in ... — diabetesjournals.org · diabetesjournals.org
- 14. Children and Adolescents: Standards of Care in Diabetes ... — diabetesjournals.org · diabetesjournals.org
- Standards of Medical Care in Diabetes—2014 — diabetesjournals.org · diabetesjournals.org
- Appendix F: Excluded studies - G.1 Review question 4.1 — www.nice.org.uk · www.nice.org.uk
- CT and MR Enterography in the Evaluation of Celiac Disease — pubs.rsna.org · pubs.rsna.org
- HLA DQ8 Antigen - an overview | ScienceDirect Topics — www.sciencedirect.com · www.sciencedirect.com
- Gluten-related disorders: monitoring and follow-up - ScienceDirect — www.sciencedirect.com · www.sciencedirect.com
- Follow-up of patients with celiac disease: Achieving compliance with treatment - ScienceDirect — www.sciencedirect.com · www.sciencedirect.com
- Nutritional Deficiencies in Celiac Disease - ScienceDirect — www.sciencedirect.com · www.sciencedirect.com